Topic - Astrazeneca

Related Stories

Medical staff prepares an AstraZeneca coronavirus vaccine during preparations at the vaccine center in Ebersberg near Munich, Germany, Monday, March 22, 2021. The pharma giant AstraZeneca has requested that its European authorization for its COVID vaccine be pulled, according to the EU medicines regulator on Wednesday, May 8, 2024. (AP Photo/Matthias Schrader, File)

AstraZeneca pulls its COVID vaccine from European market

Associated Press

Medical staff prepares a syringe from a vial of the AstraZeneca coronavirus vaccine during preparations at the vaccine center in Ebersberg near Munich, Germany, Monday, March 22, 2021. AstraZeneca said Thursday that it is withdrawing its application for approval of its COVID-19 vaccine in Switzerland because the country's medical regulator wanted to restrict its use to people over 50. (AP Photo/Matthias Schrader, File)

AstraZeneca withdraws COVID-19 vaccine from worldwide circulation

By Victor Morton - The Washington Times

Persons over 60 years old wait in observation after receiving their second dose of the AstraZeneca COVID-19 vaccine at the University Olympic Stadium in Mexico City, April 12, 2021. (AP Photo/Marco Ugarte) **FILE**

AstraZeneca admits its COVID vaccine can cause deadly blood clots

By Staff - The Washington Times

A Moderna Spikevax COVID-19 vaccine is seen at a drugstore in Cypress, Texas, Sept. 20, 2023. On Thursday, Feb. 1, 2024, the Centers for Disease Control and Prevention said the updated COVID-19 vaccine was 54% effective at preventing symptomatic infection in adults. The shot became available last year as a replacement vaccine designed to better protects against more recent COVID variants. (Melissa Phillip/Houston Chronicle via AP, File)

Study of 99 million COVID-vaccinated people finds links to brain, heart problems

By Staff - The Washington Times

In this Jan. 21, 2021, file photo a medical staff member prepares the Pfizer COVID-19 vaccine at Tudor Ranch in Mecca, Calif. With vaccination against COVID-19 in full swing, social platforms like Facebook, Instagram and Twitter say they’ve stepped up their fight against misinformation that aims to undermine trust in the vaccines. (AP Photo/Jae C. Hong, File)

‘Twitter Files’: Big Pharma pressured platform to censor COVID-19 vaccine debate

By Joseph Clark - The Washington Times

FILE - Syringes and colorful bandages are prepared as children from local schools prepare to get COVID-19 vaccines in Pittsfield, Mass., on Monday Dec. 13, 2021. A review by federal health officials finds that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently eligible for vaccination. The review issued Sunday, June 12, 2022, by the Food and Drug Administration is a key step toward a decision on vaccinations for babies, toddlers and preschoolers, perhaps as soon as June 21. (Ben Garver/The Berkshire Eagle via AP, File)

Pfizer, BioNTech now siccing experimental COVID shots on babies

By Cheryl K. Chumley - The Washington Times

COVID-19 nasal spray fails in trial by Oxford University and AstraZeneca

By Tom Howell Jr. - The Washington Times

FILE - Professor Dame Sarah Gilbert on June 11, 2021. In excerpts released ahead of a speech Monday Dec. 6, 2021, Prof. Sarah Gilbert, one of the scientists behind the Oxford-AstraZeneca COVID-19 vaccine, is warning that the next pandemic may more contagious and more lethal unless more money is devoted to research and preparations to fight emerging viral threats. (Steve Parsons/PA via AP, file)

Big Pharma, WHO, globalists tee up next virus fear

By Cheryl K. Chumley - The Washington Times

The French vaccine startup Valneva headquarters is pictured in Saint-Herblain, western France, Wednesday, Feb. 3, 2021. French pharmaceutical startup Valneva had big news in September: a government contract for 60 million doses of its coronavirus vaccine candidate. The buyer? The United Kingdom — not the European Union, as might be expected for a company on the banks of the Loire. (AP Photo/David Vincent)

French drugmaker Valneva reports positive COVID-19 vaccine results

By Tom Howell Jr. - The Washington Times

Eric Clapton, center, performs during his &quot;70th Birthday Celebration&quot; concert at Madison Square Garden on Friday, May 1, 2015, in New York. (Luiz C. Ribeiro/Invision/AP) ** FILE **

Eric Clapton plays arena with COVID-19 vaccine requirement, despite anti-mandate stance

By Tom Howell Jr. - The Washington Times

FILE - In this April 8, 2021 file photo, the Johnson &amp; Johnson COVID-19 vaccine is seen at a pop up vaccination site in the Staten Island borough of New York. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine bulk substance to resume, the company said Thursday, July 29. The Baltimore factory was shut down by the FDA in mid-April due to contamination problems that forced the company to trash the equivalent of tens of millions of doses of vaccine it was making under contract for Johnson &amp; Johnson. (AP Photo/Mary Altaffer, File)

Emergent: FDA letting troubled COVID vaccine factory restart

By Linda A. Johnson - Associated Press

House Oversight and Reform Committee Chairwoman Carolyn Maloney, D-N.Y., speaks during a House Oversight and Reform Committee regarding the on Jan. 6 attack on the U.S. Capitol, on Capitol Hill in Washington, Wednesday, May 12, 2021. (Jonathan Ernst/Pool via AP) **FILE**

House report: Top drugmakers spend more on investor perks than R&D

By Tom Howell Jr. - The Washington Times

Jens Spahn (CDU), Germany's Federal Minister of Health, comments at a press conference on the consequences of the STIKO recommendation to administer an mRNA vaccine after a first vaccination with Astrazeneca in Berlin, Germany, Friday, July 2, 2021. (Fabian Sommer/dpa via AP)

Germany recommends combination of AstraZeneca, mRNA shots

By Geir Moulson - Associated Press

Lawyers for the European Commission, left, and AstraZeneca right, prepare arguments during a hearing, European Commission vs AstraZeneca, at the main courthouse in Brussels, Wednesday, May 26, 2021. (AP Photo/Virginia Mayo)

EU takes on AstraZeneca in court over COVID-19 vaccine deliveries

By Samuel Petrequin - Associated Press

In this March 22, 2021, file photo, vials of the AstraZeneca COVID-19 vaccine sit in a fridge at the local vaccine center in Ebersberg near Munich, Germany. The European Commission will try this week to persuade a Belgian court to order the AstraZeneca pharmaceutical company to deliver millions of doses of its COVID-19 vaccines to EU countries. The EU accuses the Anglo-Swedish drugmaker of failing to deliver the number of shots it agreed. AstraZenecas contract signed with the Commission on behalf of all 27 EU member states foresaw an initial 300 million doses for distribution among member countries, with an option for a further 100 million. The doses were expected to be delivered throughout 2021 but only 30 million were sent during the first quarter. (AP Photo/Matthias Schrader, File)

AstraZeneca vaccine linked to 3 strokes

By Shen Wu Tan - The Washington Times